Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004
PHASE2/PHASE3CompletedINTERVENTIONAL
Timeline
Start Date
December 31, 2003
Study Completion Date
July 31, 2004
Conditions
Influenza
Interventions
BIOLOGICAL
Vero Cell-derived Influenza Vaccine
BIOLOGICAL
Egg-derived Influenza Vaccine
Trial Locations (1)
PL-10-461
PANTAMED Sp.z o.o., Olsztyn
All Listed Sponsors
lead
Alachua Government Services, Inc.
INDUSTRY
NCT00161837 - Comparison of the Safety and Immune Response of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2003/2004 | Biotech Hunter | Biotech Hunter